Covered recipient · General Payments record
KENNETH C ANDERSON
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$417,485.96
- Reported across 160 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $23,995.00 | 6 |
| Food and Beverage | $307.45 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $6,494.10 | 3 |
| GlaxoSmithKline, LLC. | $6,400.00 | 1 |
| Genentech, Inc. | $6,080.00 | 1 |
| Legend Biotech USA Inc. | $3,041.67 | 3 |
| Genentech USA, Inc. | $2,213.08 | 2 |
| Janssen Research & Development, LLC | $73.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Genentech USA, Inc. | $63.08 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133046919 | CMS |
| Genentech USA, Inc. | $2,150.00 | 12/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133046923 | CMS |
| Genentech, Inc. | $6,080.00 | 07/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133046915 | CMS |
| GlaxoSmithKline, LLC. | $6,400.00 | 11/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116737452 | CMS |
| Janssen Research & Development, LLC | $73.60 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077588049 | CMS |
| Legend Biotech USA Inc. | $24.98 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131690408 | CMS |
| Legend Biotech USA Inc. | $61.69 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131690438 | CMS |
| Legend Biotech USA Inc. | $2,955.00 | 12/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131690420 | CMS |
| PFIZER INC. | $4,410.00 | 01/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131169629 | CMS |
| PFIZER INC. | $2,000.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131906941 | CMS |
| PFIZER INC. | $84.10 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131589555 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.